Presentation is loading. Please wait.

Presentation is loading. Please wait.

Oxygen Control and Measure System Development Divia Patel, Angie Powe, Stacey Scheib Advisors: Dr. John Penn Dr. Paul King.

Similar presentations


Presentation on theme: "Oxygen Control and Measure System Development Divia Patel, Angie Powe, Stacey Scheib Advisors: Dr. John Penn Dr. Paul King."— Presentation transcript:

1 Oxygen Control and Measure System Development Divia Patel, Angie Powe, Stacey Scheib Advisors: Dr. John Penn Dr. Paul King

2 Project Definition §The goal of this project is to design, build, and test a device that can monitor and control blood oxygen saturation levels. §To accomplish this goal we will obtain a unit to measure both FiO2 and SaO2. This unit will be combined with a unit and the code to measure respiration and heart rate. The obtained data will be analyzed to find a correlation.

3 Why care about infant retinopathy? §Retinopathy of prematurity, formerly called retrolental fibroplasia, is a disease of the retina that prevents the eye from developing properly and can lead to permanent damage and blindness. §Survival Rates for infants under 1000g. §Early onset of blindness and its repercussions.

4

5 Important Statistics §3800 children in US affected by ROP §700-800 will develop blindness §It is the only cause of early onset so economic implications are greater. §No visual memory which affects learning and quality of life.

6 Cost Analysis §NICU cost among most expensive types of hospitalization §Improved monitoring results in better patient outcome and less time in hospital which leads to significant cost reductions l Median cost of treatment $49,457 with average stay of 49 days (varies inversely with birth weight) l Average cost of respiratory therapy $3112 with maximum value of $237,032

7 What causes retinopathy? §In premature infants, the normal growth of the retinal vessels stops, and abnormal new vessels begin to grow; this is usually associated with fluctuation in blood oxygen levels.

8 Specific Problem & Our Solution §There is still vast fluctuations in the blood oxygen saturation levels despite monitoring and control with present methods. §Our solution creates a smart monitoring system of blood oxygen saturation levels that incorporates specific protocols to adjust delivery of oxygen.

9 Coefficient of Variation §Measured from blood gas analysis (PaO2) §Equals standard deviation /mean §In rat and human studies 1 st five days showed tight correlation and likelihood of infant progressing to threshold ROP

10 What is our objective?  Design a smart monitoring and control system to minimize fluctuations in blood oxygen saturation levels.

11 Action Plan § Current Status l Literature Research Performed l Established Contacts: Dr. Dan Lindstrom, Dr. Jackie York l Viewed timestamped SaO2 data from Dr. Lindstrom l Contacted Ohmeda & obtained oxycap monitoring unit l Contacted Benoit Dewant and Patrick Norris on program code for linking Simon with oxycap monitoring unit l Obtained labtop to connect with oxycap and retain data.

12 Future Goals l Obtain timestampted FiO2, SaO2, respiratory rate, and heart rate data for analysis l Design and build smart monitoring and control unit l Get prototype breadboard and power supplies l Select optical sensor and A/D converter l Sketch tentative circuit and calculate circuit values l Build analog circuit, take in vitro measurements, and connect analog circuit to the A/D converter l Obtain oxygen sensor and oxygen blender

13 Future Implications §Standard of care between hospitals is different §ROP numbers are very conservative §Post-operative patients §Frees nurses time §Decrease NICU noise pollution §Severe Asthma Patients  Diving Equipment

14 Weekly Scheduled Meetings §All Group Members will work individually at their convenience. §Meet as a group:Weekly on Monday evenings @ 7pm §Group Members meet with Dr. Penn Weekly on Fridays @ 12:00 p.m.

15 Highlight of Articles Read by Group Members §Fanconi, et al. Pulse oximetry in pediatric intensive care: Comparison with measured saturations and transcutaneous oxygen tension.The Journal of Pediatrics. §Deckardt, et al. Noninvasive arterial hemoglobin oxygen saturation versus transcutaneous oxygen tension monitoring in the preterm infant. Critical Care Medicine. §Morozoff, P.E., Evans, R.W. Closed-loop Control of SaO 2 in the Neonate. Biomedical Instrumentation & Technology. §Smith, et al. Automated End-Tidal CO2 Monitoring in the Postoperative Patient §Rogowski, J. Measuring the Cost of Neonatal and Perinatal Care. Pediatrics §Dr. John Penn, Vanderbilt University


Download ppt "Oxygen Control and Measure System Development Divia Patel, Angie Powe, Stacey Scheib Advisors: Dr. John Penn Dr. Paul King."

Similar presentations


Ads by Google